NR1H4 and metabolic dysfunction-associated steatotic liver disease: Moreover, TMAO may play role in the development and progression of MASLD by enhancing oxidative stress [54] and aggravating hepatic fat accumulation by inhibition of the farnesoid X receptor signaling [55].